DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
Clinical trial NCT00889408 · COMPLETED
Trial details
- NCT number
- NCT00889408
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2014-07-21
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.